Company Overview

DATATRAK International, Inc. operates in the life sciences and healthcare technology sector, providing cloud-based software and related services used in clinical research and clinical trial management. The company’s primary focus is electronic data capture (EDC), clinical data management, and related eClinical technologies that support pharmaceutical, biotechnology, and medical device companies, as well as contract research organizations (CROs). Its offerings are designed to improve the collection, management, and analysis of clinical trial data while supporting regulatory compliance requirements in global studies.

The company historically developed its business around hosted software platforms for clinical trial automation and data integrity. Over time, DATATRAK evolved from traditional clinical data management services into a software-centric provider of web-based clinical trial technologies. Public filings and company disclosures indicate that its competitive positioning has centered on configurable clinical trial platforms, customer support capabilities, and experience serving small-to-mid-sized life sciences organizations. Available public information suggests the company has maintained a relatively niche position within the broader eClinical software market.

Business Operations

DATATRAK generates revenue primarily through subscription-based software services, hosting arrangements, implementation support, and related professional services tied to clinical trial management systems. Its operations have historically revolved around the DATATRAK eClinical platform, which includes electronic data capture functionality, clinical trial management capabilities, and tools intended to support regulatory compliance and workflow management for research studies. Revenue sources have included software licensing, recurring hosting fees, and service-based engagements associated with study configuration and support.

The company’s operations have included both domestic and international activities, with clients and study deployments extending beyond the United States into global clinical research markets. Public disclosures identify the company as maintaining technology infrastructure and software assets central to its hosted platform strategy. While DATATRAK has collaborated with pharmaceutical and clinical research organizations through customer engagements, publicly available information does not consistently identify large-scale joint ventures or material strategic partnerships in recent filings. Data regarding active subsidiaries or extensive international operating divisions is limited in current public disclosures.

Strategic Position & Investments

DATATRAK’s strategic direction has focused on maintaining and enhancing its clinical trial software offerings while serving regulated healthcare and life sciences customers requiring validated electronic systems. The company has historically emphasized product development and operational support for electronic clinical data management rather than pursuing broad diversification outside the eClinical technology space. Public filings indicate that management has concentrated on operational efficiency, customer retention, and technology platform maintenance within a competitive clinical research software environment.

Available public information does not indicate significant recent acquisitions or large-scale investment activity comparable to larger publicly traded healthcare technology firms. The company’s involvement in emerging sectors appears primarily connected to digital clinical trial infrastructure, cloud-hosted research systems, and electronic regulatory-compliant data management. Data regarding material portfolio investments, venture holdings, or major acquisition programs is inconclusive based on available public sources.

Geographic Footprint

DATATRAK International, Inc. is headquartered in the United States, with historical operations centered in the domestic clinical research technology market. Company disclosures and prior public filings indicate that its software platform has been used in multinational clinical studies spanning regions including North America, Europe, and parts of Asia-Pacific, reflecting the global nature of pharmaceutical research and CRO operations.

Although the company has maintained international customer reach through hosted technology deployments and clinical trial support activities, publicly available information suggests its operational scale is comparatively limited relative to larger global eClinical providers. Information regarding current physical office distribution, international subsidiaries, or significant foreign operational infrastructure is limited in recent public filings.

Leadership & Governance

DATATRAK International, Inc. has historically been governed through a traditional public-company board and executive leadership structure focused on healthcare technology and clinical research operations. Public filings indicate that company leadership has emphasized regulatory compliance, operational discipline, and maintenance of long-term customer relationships within the clinical trial technology sector. The company’s governance and reporting practices have been documented through periodic filings with the SEC and related public disclosures.

Key executives and leadership figures identified in publicly available records include:

• Laurence P. Birch – Chairman and Chief Executive Officer
• Richard J. Franco – Executive Vice President and Chief Financial Officer

Data regarding additional current executive officers, expanded leadership teams, or updated governance structures is inconclusive based on available public sources.